Danaher (DHR) delivered better-than-expected Q3 2021 results for the period ended October 1, 2021. Revenue and earnings came in above consensus estimates as the company continued to expand its production capacity and innovation initiatives. DHR shares fell 1.30% to close at $310.74 on October 21. Danaher is a U.S. company that designs, manufactures, and sells medical, industrial, and commercial products and services worldwide. It operates under three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Net earnings in the quarter landed at $1.2 billion while adjusted diluted net earnings per common share increased 39% year-over-year to $2.39. Analysts were expecting EPS of $2.15.
https://www.tipranks.com/news/danaher-q3-earnings-and-revenue-top-estimates?utm_source=advfn.com&utm_medium=referral
Danaher (NYSE:DHR)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Danaher Charts.
Danaher (NYSE:DHR)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Danaher Charts.